Parabilis Medicines, Inc. (PBLS)
30.37
+1.84
(+6.45%)
USD |
NASDAQ |
Nov 09, 16:00
29.77
-0.60
(-1.98%)
After-Hours: 20:00
Parabilis Medicines Market Cap : 3.751B for Nov. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 09, 2026 | 3.751B |
| November 06, 2026 | 3.524B |
| November 05, 2026 | 3.444B |
| November 04, 2026 | 3.750B |
| November 03, 2026 | 3.613B |
| November 02, 2026 | 3.366B |
| October 30, 2026 | 3.498B |
| October 29, 2026 | 3.545B |
| October 28, 2026 | 3.480B |
| October 27, 2026 | 3.275B |
| October 26, 2026 | 3.092B |
| October 23, 2026 | 3.019B |
| October 22, 2026 | 3.325B |
| October 21, 2026 | 3.440B |
| October 20, 2026 | 3.345B |
| October 19, 2026 | 3.131B |
| October 16, 2026 | 2.810B |
| October 15, 2026 | 3.110B |
| October 14, 2026 | 3.198B |
| October 13, 2026 | 3.317B |
| October 12, 2026 | 3.576B |
| October 09, 2026 | 3.394B |
| October 08, 2026 | 3.470B |
| October 07, 2026 | 3.560B |
| October 06, 2026 | 3.565B |
| Date | Value |
|---|---|
| October 05, 2026 | 3.648B |
| October 02, 2026 | 3.740B |
| October 01, 2026 | 3.760B |
| September 30, 2026 | 3.988B |
| September 29, 2026 | 3.942B |
| September 28, 2026 | 4.023B |
| September 25, 2026 | 3.854B |
| September 24, 2026 | 4.011B |
| September 23, 2026 | 4.114B |
| September 22, 2026 | 4.715B |
| September 21, 2026 | 4.562B |
| September 18, 2026 | 5.154B |
| September 17, 2026 | 5.049B |
| September 16, 2026 | 4.555B |
| September 15, 2026 | 4.412B |
| September 14, 2026 | 4.466B |
| September 11, 2026 | 4.555B |
| September 10, 2026 | 4.486B |
| September 09, 2026 | 4.788B |
| September 08, 2026 | 4.912B |
| September 04, 2026 | 4.993B |
| September 03, 2026 | 5.033B |
| September 02, 2026 | 4.954B |
| September 01, 2026 | 4.875B |
| August 31, 2026 | 4.819B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 6.949B |
| Oncolytics Biotech, Inc. | 50.81M |
| Sangamo Therapeutics, Inc. | 45.57M |
| Sarepta Therapeutics, Inc. | 1.849B |
| Anixa Biosciences, Inc. | 109.29M |
Market Cap Related Metrics
| PS Ratio | 24795.23 |
| Price to Book Value | 3.580 |
| Price | 30.37 |
| Earnings Yield | -6.30% |